You are here

  • Home
  • Archive
  • Volume 3, Issue 1
  • Baseline circulating IL-17 predicts toxicity while TGF-β1 and IL-10 are prognostic of relapse in ipilimumab neoadjuvant therapy of melanoma

Article metrics

Article menu

Download PDFPDF

XML
Research Article
Baseline circulating IL-17 predicts toxicity while TGF-β1 and IL-10 are prognostic of relapse in ipilimumab neoadjuvant therapy of melanoma

 

Online download statistics by month:

Online download statistics by month: December 2019 to July 2022

AbstractFullPdf
Dec 2019220
Jan 2020884
Feb 202017172
Mar 2020772
Apr 202017174
May 202028283
Jun 202010100
Jul 202011113
Aug 202016161
Sep 202030302
Oct 202032326
Nov 202023234
Dec 202019193
Jan 202116168
Feb 202124244
Mar 2021303015
Apr 2021373721
May 2021383812
Jun 202134348
Jul 202167678
Aug 202151518
Sep 2021737318
Oct 202156569
Nov 2021797719
Dec 2021515410
Jan 2022505211
Feb 2022586320
Mar 202210410913
Apr 2022879015
May 2022878917
Jun 2022727813
Jul 202264665
Total12981324268